A Potential Role for Pharmacologic Phosphodiesterase 5 Inhibitors in the Treatment of Obstructive Sleep Apnea

J Cardiovasc Pharmacol. 2024 Jul 1;84(1):32-33. doi: 10.1097/FJC.0000000000001527.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism
  • Humans
  • Phosphodiesterase 5 Inhibitors* / pharmacology
  • Phosphodiesterase 5 Inhibitors* / therapeutic use
  • Sleep Apnea, Obstructive* / drug therapy
  • Sleep Apnea, Obstructive* / physiopathology
  • Treatment Outcome

Substances

  • Phosphodiesterase 5 Inhibitors
  • Cyclic Nucleotide Phosphodiesterases, Type 5